158 related articles for article (PubMed ID: 19860433)
1. Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine.
Bender DM; Bao J; Dantzig AH; Diseroad WD; Law KL; Magnus NA; Peterson JA; Perkins EJ; Pu YJ; Reutzel-Edens SM; Remick DM; Starling JJ; Stephenson GA; Vaid RK; Zhang D; McCarthy JR
J Med Chem; 2009 Nov; 52(22):6958-61. PubMed ID: 19860433
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of oral prodrugs based on the structure of gemcitabine.
Zhao C; Xue X; Li G; Sun C; Sun C; Qu X; Li W
Chem Biol Drug Des; 2012 Sep; 80(3):479-88. PubMed ID: 22642666
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties.
Hong S; Fang Z; Jung HY; Yoon JH; Hong SS; Maeng HJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314360
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine-coumarin-biotin conjugates: a target specific theranostic anticancer prodrug.
Maiti S; Park N; Han JH; Jeon HM; Lee JH; Bhuniya S; Kang C; Kim JS
J Am Chem Soc; 2013 Mar; 135(11):4567-72. PubMed ID: 23461361
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cellular uptake and intracellular drug controlled release of VESylated gemcitabine prodrug nanocapsules.
Fang Y; Du F; Xu Y; Meng H; Huang J; Zhang X; Lu W; Liu S; Yu J
Colloids Surf B Biointerfaces; 2015 Apr; 128():357-362. PubMed ID: 25746328
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of a gemcitabine phosphoramidate prodrug.
Wu W; Sigmond J; Peters GJ; Borch RF
J Med Chem; 2007 Jul; 50(15):3743-6. PubMed ID: 17602464
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Antitumor Activity of Monophosphate Ester Prodrugs of Gemcitabine: In Vitro and In Vivo Evaluation.
Qi H; Lu J; Li J; Wang M; Xu Y; Wang Y; Zhang H
J Pharm Sci; 2016 Sep; 105(9):2966-2973. PubMed ID: 26994559
[TBL] [Abstract][Full Text] [Related]
8. A facile route to heterotelechelic polymer prodrug nanoparticles for imaging, drug delivery and combination therapy.
Vinciguerra D; Denis S; Mougin J; Jacobs M; Guillaneuf Y; Mura S; Couvreur P; Nicolas J
J Control Release; 2018 Sep; 286():425-438. PubMed ID: 30099018
[No Abstract] [Full Text] [Related]
9. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine.
Tsume Y; Drelich AJ; Smith DE; Amidon GL
Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma.
Stephenson AA; Cao S; Taggart DJ; Vyavahare VP; Suo Z
Eur J Med Chem; 2021 Mar; 213():113135. PubMed ID: 33454548
[TBL] [Abstract][Full Text] [Related]
11. Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport.
Song X; Lorenzi PL; Landowski CP; Vig BS; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(2):157-67. PubMed ID: 15804190
[TBL] [Abstract][Full Text] [Related]
12. Regioselective synthesis and anticancer evaluation of H
Sun YJ; Liu L; Cheng L
Chem Commun (Camb); 2020 Jun; 56(48):6484-6487. PubMed ID: 32458844
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles with in vivo anticancer activity from polymer prodrug amphiphiles prepared by living radical polymerization.
Harrisson S; Nicolas J; Maksimenko A; Bui DT; Mougin J; Couvreur P
Angew Chem Int Ed Engl; 2013 Feb; 52(6):1678-82. PubMed ID: 23255475
[No Abstract] [Full Text] [Related]
14. Self-Delivery Janus-Prodrug for Precise Immuno-Chemotherapy of Colitis-Associated Colorectal Cancer.
Zhang Q; Li S; Bai L; Yu D; Li H; Tong R
ACS Appl Mater Interfaces; 2022 Jan; 14(1):297-306. PubMed ID: 34958191
[TBL] [Abstract][Full Text] [Related]
15. N-Acyl-phosphoramidates as potential novel form of gemcitabine prodrugs.
Baraniak J; Pietkiewicz A; Kaczmarek R; Radzikowska E; Kulik K; Krolewska K; Cieslak M; Krakowiak A; Nawrot B
Bioorg Med Chem; 2014 Apr; 22(7):2133-40. PubMed ID: 24631359
[TBL] [Abstract][Full Text] [Related]
16. Stereocomplex Prodrugs of Oligo(lactic acid)
Tam YT; Huang C; Poellmann M; Kwon GS
ACS Nano; 2018 Jul; 12(7):7406-7414. PubMed ID: 29957934
[TBL] [Abstract][Full Text] [Related]
17. Polymer prodrug nanoparticles based on naturally occurring isoprenoid for anticancer therapy.
Trung Bui D; Maksimenko A; Desmaële D; Harrisson S; Vauthier C; Couvreur P; Nicolas J
Biomacromolecules; 2013 Aug; 14(8):2837-47. PubMed ID: 23829862
[TBL] [Abstract][Full Text] [Related]
18. Interaction of a new anticancer prodrug, gemcitabine-squalene, with a model membrane: coupled DSC and XRD study.
Pili B; Bourgaux C; Amenitsch H; Keller G; Lepêtre-Mouelhi S; Desmaële D; Couvreur P; Ollivon M
Biochim Biophys Acta; 2010 Aug; 1798(8):1522-32. PubMed ID: 20435013
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.
Bergman AM; Adema AD; Balzarini J; Bruheim S; Fichtner I; Noordhuis P; Fodstad O; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Invest New Drugs; 2011 Jun; 29(3):456-66. PubMed ID: 20066470
[TBL] [Abstract][Full Text] [Related]
20. Self-Assembled Gemcitabine Prodrug Nanoparticles Show Enhanced Efficacy against Patient-Derived Pancreatic Ductal Adenocarcinoma.
Wu L; Zhang F; Chen X; Wan J; Wang Y; Li T; Wang H
ACS Appl Mater Interfaces; 2020 Jan; 12(3):3327-3340. PubMed ID: 31872760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
